Cancer treatment using very high-dose chemotherapy or radiation therapy often results in severe injury to a patient’s blood-forming cells, called their hematopoietic (“blood formation”) system. Therefore, radiation therapy is soon followed by hematopoietic stem cell transplantation (HSCT), which is a method of reconstructing a patient’s blood system that has been destroyed by cancer treatment. Cord blood can also be used as a source of stem cells for hematopoietic stem cell transplantation (HSCT), providing an important alternative to the traditional options of peripheral blood and bone marrow transplant. Importantly, bone marrow and peripheral blood require full tissue matching for use in HSCT, while umbilical cord blood only requires partial matching. [Read more…]
Cord Blood
Because cord blood present within a newborn’s umbilical is rich with stem cells, it can be collected and stored for future medical use.
Cord Blood vs. Cord Tissue Stem Cells: What are the Differences?
There are cells contained within a newborn’s umbilical cord blood and cord tissue that can be collected and stored for potential medical use. In this article, we explore the differences between these valuable cell types and how they may be used within the growing field of regenerative medicine (RM).
Read on to learn about the differences and potential uses of umbilical cord blood versus cord tissue stem cells.
In this article:
Cell Therapy Industry News Round-Up: November 2, 2025
The Cell and Gene Therapy Industry Accelerates with New Financing, Partnerships, and Clinical Milestones
The cell and gene therapy (CGT) sector is entering the final quarter of 2025 with remarkable momentum, driven by major financing rounds, strategic partnerships, manufacturing advances, and promising clinical data. Collectively, these developments highlight a sector that continues to mature, moving from scientific promise to commercial and clinical reality. [Read more…]
List of U.S. FDA Approved Cell and Gene Therapy Products (46)
Today, researchers and clinicians are under great pressure to develop therapies capable of reversing or significantly impacting the progression of disease. In recent years, the arrival of the cell and gene therapy industries have introduced the possibility of providing transformative, durable and potentially curative outcomes for a diverse range of life-threatening conditions, as well as injuries, degenerative diseases, genetic disorders, and cancers. [Read more…]
Legendary NFL Quarterback Bernie Kosar Launches X Pro. Athlete Cognitive Longevity Wellness Program to Push the Limits of Brain Performance with Crowley Center for Regenerative Biotherapeutics in collaboration with global biotech manufacturer Regenerelle®, LLC, and trial sponsor The Crowley Center for Regenerative Biotherapeutics, LLC.
Backed by a $10M Age Zero™ Regenerelle® in-kind contribution by the Crowley Family, Team Bernie™ brings together NFL veterans and longevity innovators to explore next-generation cognitive optimization.
COLUMBUS, OH / FORT LAUDERDALE, FL / ROCHESTER, NY, October 23, 2025 – In a world focused on optimizing the body — from cold plunges to peptides — one team is taking on the next frontier: the brain.
Renewing Athletes’ Lives™ (RAL), co-founded by Michael Crowley, Erin Crowley, and Bernie Kosar, today announced the launch of Team Bernie™, a Cognitive Longevity Program exploring how targeted brain-support strategies may help athletes sharpen focus, clarity, and mental resilience long after their playing careers ends. [Read more…]
- « Previous Page
- 1
- …
- 5
- 6
- 7
- 8
- 9
- …
- 62
- Next Page »




